Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Rama Makkena"'
Autor:
Michael E. Luggen, M Weisman, Thomas Taylor, John J. Cush, William G. Henderson, Richard H. Ward, F. Paul Alepa, H. Ralph Schumacher, Grant W. Cannon, Miriam Richter Cohen, Elly Budiman-Mak, Joel Buxbaum, John R. Ward, Edwin Mejias, Daniel O. Clegg, Rama Makkena, F Vasey, Domenic J. Reda, Stuart L. Silverman, Maren L. Mahowald, Warren D. Blackburn, Robert J. Anderson, Clair M. Haakenson, B.J. Manaster
Publikováno v:
Arthritis and rheumatism. 39(12)
Objective. To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is effective for the treatment of active ankylosing spondylitis (AS) that is not controlled with nonsteroidal antiinflammatory drug therapy. Methods. Two hundred sixty-fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feb73b20516827e73086de05b113ba17
https://pubmed.ncbi.nlm.nih.gov/8961905
https://pubmed.ncbi.nlm.nih.gov/8961905
Autor:
Richard H. Ward, Elly Budiman-Mak, Clair M. Haakenson, Grant W. Cannon, Daniel O. Clegg, John J. Cush, Nourollah Parhami, F. Paul Alepa, H. Ralph Schumacher, M Weisman, B.J. Manaster, Stuart L. Silverman, Dominic J. Balestra, Jean Higashida, Joel Buxbaum, John R. Ward, Warren D. Blackburn, F Vasey, Rama Makkena, Miriam Richter Cohen, Maren L. Mahowald, Robert D. Inman, Edwin Mejias, Robert J. Anderson, William G. Henderson, Domenic J. Reda
Publikováno v:
Arthritis and rheumatism. 39(12)
To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is effective in the treatment of reactive arthritis (ReA) that has been unresponsive to nonsteroidal antiinflammatory drug (NSAID) therapy.One hundred thirty-four patients with ReA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b7189438e693f677acf9a126369992b
https://pubmed.ncbi.nlm.nih.gov/9336437
https://pubmed.ncbi.nlm.nih.gov/9336437